3,243
Views
15
CrossRef citations to date
0
Altmetric
Special Review: IL-6 inhibitor

The benefits and prospects of interleukin-6 inhibitor on systemic sclerosis

Pages 294-301 | Received 28 Sep 2018, Accepted 13 Dec 2018, Published online: 06 Feb 2019

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.